AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion

AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.#astrazeneca
Source: Reuters: Health - Category: Consumer Health News Source Type: news